Optel High-Tech Microelectronics Solutions is specialized in providing customized high technological microelectronic solutions, matching the needs of industrial customers. Founded in 1990 by leading private companies in the aerospace, aeronautics and defence sectors, as well as primary public research institutions (above all, the Consiglio Nazionale delle Ricerche), university and research centers. Optel is partner of Finmeccanica – Leonardo
Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick. Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel.
ARITHMOS Life Sciences provides IT products and services to companies in the health science sector wanting to improve efficiency, project governance and data management processes. We support companies conducting clinical trials including CROs, pharmaceutical, biotechnology and medical device companies and academic institutions. We streamline technology processes, implement new and customized solutions and maintain data and system quality according to GxP regulations
Cros Nt originally established as a specialist biometrics Contract Research Organization, CROS NT remains a data centric CRO providing services globally from feasibility to clinical study report for Phases I-IV and medical device trials. CROS NT’s contribution usually starts in early phase development where we support with expert clinical and statistical study design and regulatory consultancy. We provide “consultancy with deliverables” such as protocols, evidenced based feasibility, regulatory plan, and an outsourced monitoring solution. Services include data management, biostatistics programming & analysis, pharmacovigilance and medical writing – and accompanying eClinical applications (EDC, CTMS, IWRS, ePRO) for all phases and medical device studies. We offer a center for Sponsors’ clinical data across a program of studies, facilitating excellent data visualization, risk based monitoring, meta-analysis, standardization, traceability and efficiencies that substantially reduce costs. All services are underpinned by strong clinical and biometrics project management.